Targeted Disruption of PKC from AKAP Signaling Complexes
Overview
Affiliations
Protein Kinase C (PKC) is a member of the AGC subfamily of kinases and regulates a wide array of signaling pathways and physiological processes. Protein-protein interactions involving PKC and its scaffolding partners dictate the spatiotemporal dynamics of PKC activity, including its access to activating second messenger molecules and potential substrates. While the A Kinase Anchoring Protein (AKAP) family of scaffold proteins universally bind PKA, several were also found to scaffold PKC, thereby serving to tune its catalytic output. Targeting these scaffolding interactions can further shed light on the effect of subcellular compartmentalization on PKC signaling. Here we report the development of two hydrocarbon stapled peptides, CSTAD5 and CSTAD6, that are cell permeable and bind PKC to disrupt PKCgravin complex formation in cells. Both constrained peptides downregulate PMA-induced cytoskeletal remodeling that is mediated by the PKCgravin complex as measured by cell rounding. Further, these peptides downregulate PKC substrate phosphorylation and cell motility. To the best of our knowledge, no PKC-selective AKAP disruptors have previously been reported and thus CSTAD5 and CSTAD6 are novel disruptors of PKC scaffolding by AKAPs and may serve as powerful tools for dissecting AKAP-localized PKC signaling.
The SH3-binding domain of chorismate mutase protein of contributes to mycobacterial virulence.
Pal R, Maurya V, Borah S, Mukhopadhyay S iScience. 2024; 27(11):111044.
PMID: 39507252 PMC: 11539714. DOI: 10.1016/j.isci.2024.111044.
Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTAC.
Whittaker M, Bendzunas G, Shirani M, LeClair T, Shebl B, Dill T ACS Chem Biol. 2024; 19(9):1888-1895.
PMID: 39137166 PMC: 11420944. DOI: 10.1021/acschembio.4c00237.
Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment.
Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X Front Endocrinol (Lausanne). 2024; 14:1265372.
PMID: 38264279 PMC: 10803883. DOI: 10.3389/fendo.2023.1265372.
Silnitsky S, Rubin S, Zerihun M, Qvit N Int J Mol Sci. 2023; 24(24).
PMID: 38139428 PMC: 10743896. DOI: 10.3390/ijms242417600.
Optimized Stapled Peptides Targeting WASF3 in Breast Cancer.
Limaye A, Bendzunas G, Whittaker M, LeClair T, Helton L, Kennedy E ACS Med Chem Lett. 2022; 13(4):570-576.
PMID: 35450347 PMC: 9014496. DOI: 10.1021/acsmedchemlett.1c00627.